GO:0010952 positive regulation of peptidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010952 describes any biological process that increases the frequency, rate, or extent of peptidase activity, which is the hydrolysis of peptide bonds within proteins.
• Positive regulation of peptidase activity is essential for diverse physiological events, including blood coagulation, apoptosis, viral polyprotein processing, and extracellular matrix remodeling.
• Key regulatory mechanisms include allosteric control by endogenous phospholipids, exosite crosstalk in thrombin, autolytic activation of kallikrein-related peptidases, and phosphorylation-dependent stabilization of proteases.
• Dysregulation of peptidase activity is linked to cancer progression, neurodegenerative disorders, and viral pathogenesis, making it a target for therapeutic intervention.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of genes that positively regulate peptidase activity.
• Studying GO:0010952 requires integrated approaches such as protease activity assays, phosphoproteomics, and CRISPR library screening to identify upstream regulators.
Description
Peptidases, also known as proteases, are enzymes that catalyze the hydrolysis of peptide bonds, a fundamental post-translational modification that controls protein function, localization, and lifespan. The Gene Ontology term GO:0010952, positive regulation of peptidase activity, encompasses any process that increases the frequency, rate, or extent of this hydrolytic activity. This regulation is critical because uncontrolled proteolysis can lead to pathological states, while insufficient peptidase activity can impair essential processes such as blood clotting, immune response, and tissue remodeling. Researchers study GO:0010952 to understand how cells modulate proteolytic cascades in health and disease. For example, the coagulation protease thrombin is regulated by exosite crosstalk, which fine-tunes its substrate specificity and activity. Similarly, the autolytic regulation of human kallikrein-related peptidase 6 demonstrates how self-cleavage can positively regulate enzymatic function. In viral infections, allosteric regulation of Senecavirus A 3Cpro by an endogenous phospholipid enhances proteolytic activity essential for viral replication. These examples highlight the diversity of mechanisms that positively regulate peptidase activity. Understanding these processes has broad implications for drug discovery, as peptidases are among the most successful drug targets. Moreover, the interplay between peptidase activity and cellular signaling pathways, such as the CHK2-USP7-p53 axis under oxidative stress, underscores the importance of positive regulation in stress responses and cancer. This article synthesizes current knowledge on GO:0010952, covering its definition, mechanisms, key genes, disease relevance, and experimental models, with a focus on CRISPR-based approaches for functional studies.
positive regulation of peptidase activity At A Glance
| GO ID | GO:0010952 |
|---|---|
| GO term | positive regulation of peptidase activity |
| Ontology | biological_process |
| Synonym | none |
| Major function | Increases the frequency, rate or extent of peptidase activity, the hydrolysis of peptide bonds within proteins |
| Related processes | Blood coagulation, apoptosis, viral polyprotein processing, extracellular matrix remodeling |
| Key regulators | Thrombin exosites, kallikrein-related peptidases, viral 3Cpro, CHK2-USP7 axis |
| Disease relevance | Cancer, neurodegeneration, viral infections, thrombosis |
What Is GO:0010952?
According to the Gene Ontology, GO:0010952 (positive regulation of peptidase activity) is defined as any process that increases the frequency, rate or extent of peptidase activity, the hydrolysis of peptide bonds within proteins. In simpler terms, it includes all molecular events that enhance the ability of a peptidase enzyme to break down other proteins. This regulation can occur at multiple levels, including allosteric activation, post-translational modifications, protein-protein interactions, and changes in subcellular localization.
Why Is positive regulation of peptidase activity Important in Cell Biology?
Positive regulation of peptidase activity is a central control point in numerous physiological and pathological processes. Peptidases are involved in virtually every aspect of biology, from digestion and blood clotting to immune defense and cell death. Their activity must be tightly regulated because excessive proteolysis can destroy tissues, while insufficient activity can lead to accumulation of damaged proteins or failure to activate critical signaling molecules. For instance, the coagulation cascade relies on a series of positive regulatory events that amplify thrombin generation, and defects in this regulation can cause bleeding or thrombotic disorders. In cancer, peptidases such as kallikrein-related peptidases promote tumor invasion and metastasis, and their positive regulation is often hijacked by cancer cells. Viral pathogens also exploit positive regulation of peptidase activity; for example, Senecavirus A 3Cpro requires an endogenous phospholipid for optimal proteolytic processing of the viral polyprotein. Therefore, understanding GO:0010952 offers insights into fundamental biology and provides a rationale for developing therapeutics that modulate peptidase activity.
• Peptidases are essential for protein turnover and post-translational processing, and their positive regulation ensures timely activation of signaling cascades.
• Dysregulated peptidase activity contributes to cancer progression, where proteases like kallikrein-related peptidases promote invasion and metastasis.
• In neurodegenerative diseases, altered peptidase activity can lead to protein aggregation or neuronal death, highlighting the need for balanced regulation.
• Viral proteases, such as Senecavirus A 3Cpro, require positive regulation for efficient viral replication, making them antiviral targets.
• Thrombin exosite crosstalk exemplifies how positive regulation of peptidase activity is critical for hemostasis and thrombosis.
• The CHK2-USP7 positive feedback loop stabilizes p53 under oxidative stress, linking peptidase regulation to DNA damage responses.
• Positive regulation of peptidase activity is involved in apoptosis through ASK1 activation by DUSP13A.
• Exercise-induced changes in systemic biomarkers may reflect altered peptidase activity in metabolic and cognitive health.
• CRISPR screens can identify novel regulators of peptidase activity, accelerating target discovery.
• Understanding positive regulation of peptidase activity can guide development of protease inhibitors and activators for therapeutic use.
What Happens During positive regulation of peptidase activity?
Allosteric Activation by Endogenous Ligands
In simple terms: A small molecule binds to the peptidase and changes its shape to make it more active.
Allosteric regulation is a common mechanism for positively regulating peptidase activity. For example, the 3C protease (3Cpro) of Senecavirus A is allosterically activated by an endogenous phospholipid, which enhances its proteolytic activity essential for viral polyprotein processing. This binding likely induces conformational changes that optimize the active site for substrate cleavage. Similarly, thrombin activity is modulated by exosite crosstalk, where binding of cofactors or substrates at one exosite influences the active site and other exosites, leading to enhanced or altered specificity. These examples illustrate how allosteric effectors can positively regulate peptidase activity in a highly specific manner.
Autolytic Activation and Processing
In simple terms: The peptidase cuts itself to become active.
Many peptidases are synthesized as inactive zymogens and require autolytic cleavage for activation. Human kallikrein-related peptidase 6 (KLK6) undergoes autolytic regulation, where self-cleavage events lead to increased enzymatic activity. This autolytic processing can be triggered by changes in pH, ionic strength, or interaction with cofactors. The resulting active peptidase can then cleave downstream substrates, amplifying the proteolytic cascade. Autolytic activation is a key positive regulatory mechanism that ensures peptidases are activated only when needed.
Post-translational Modifications and Stability
In simple terms: Adding chemical tags to the peptidase or its regulators can make it more active or stable.
Phosphorylation and deubiquitination are critical post-translational modifications that positively regulate peptidase activity. The CHK2-USP7 axis forms a positive feedback loop that stabilizes p53 under oxidative stress; USP7 is a deubiquitinase that removes ubiquitin from p53, preventing its degradation and allowing p53 to activate downstream targets, including peptidases involved in apoptosis. Additionally, dual-specificity phosphatase 13A (DUSP13A) positively regulates apoptosis signal-regulating kinase 1 (ASK1), which can lead to activation of downstream peptidases such as caspases. These modifications often alter protein-protein interactions or subcellular localization, thereby enhancing peptidase function.
Cofactor and Exosite Interactions
In simple terms: Helper proteins or ions bind to the peptidase and boost its activity.
Cofactors and exosites play crucial roles in positive regulation. Thrombin, a serine peptidase, has two exosites: one for fibrinogen binding and another for thrombomodulin. Exosite crosstalk allows thrombin to switch substrate specificity and enhance activity toward certain substrates. In the case of Zika virus NS3 helicase, mechanical regulation of its activity is coupled to nucleic acid binding, which may also influence its protease domain. These interactions demonstrate how cofactors and exosites can positively regulate peptidase activity by promoting substrate binding or catalysis.
Transcriptional and Translational Control
In simple terms: Cells can make more peptidase or more of its activators to increase activity.
While much regulation occurs post-translationally, transcriptional and translational control can also positively regulate peptidase activity. For instance, aerobic exercise training alters systemic biomarkers, potentially including peptidases, in late middle-aged adults at risk for Alzheimer's disease. Although the exact peptidases were not specified, this study suggests that physiological stimuli can modulate peptidase levels. Similarly, viral infection can induce expression of host peptidases that facilitate viral entry or replication. Thus, increased synthesis of peptidases or their activators represents another layer of positive regulation.
Key Genes Involved in GO:0010952 positive regulation of peptidase activity
The following genes and proteins are key players in the positive regulation of peptidase activity, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| F2 (Thrombin) | Serine peptidase with exosite crosstalk that enhances substrate specificity and activity | Model for allosteric regulation and hemostasis; target for anticoagulants |
| KLK6 | Kallikrein-related peptidase 6 undergoes autolytic activation to increase activity | Implicated in cancer and neurodegeneration; model for autolytic regulation |
| CHK2 | Checkpoint kinase 2 phosphorylates downstream targets to stabilize p53 under oxidative stress | Links DNA damage response to peptidase regulation; cancer research |
| USP7 | Deubiquitinase that stabilizes p53 and forms positive feedback loop with CHK2 | Target for cancer therapy; regulates peptidase-dependent apoptosis |
| DUSP13A | Dual-specificity phosphatase that positively regulates ASK1, leading to caspase activation | Apoptosis signaling; potential tumor suppressor |
| ASK1 | Apoptosis signal-regulating kinase 1 activated by DUSP13A, downstream of peptidase cascades | Stress response and cell death; drug target |
| Senecavirus A 3Cpro | Viral protease allosterically activated by endogenous phospholipid | Antiviral target; model for allosteric regulation |
| Zika virus NS3 | Helicase/protease with mechanically regulated activity | Antiviral target; understanding flavivirus replication |
| PRDM1 | Transcriptional repressor regulated by USP7; affects CD8+ T cell activity | Cancer immunotherapy; linked to peptidase regulation |
| FGL1 | Fibrinogen-like protein 1 upregulated by PRDM1; immune checkpoint | Liver cancer; immune evasion |
| p53 | Tumor suppressor stabilized by CHK2-USP7 axis; activates peptidases in apoptosis | Cancer research; central to stress responses |
| Caspases | Executioner peptidases activated downstream of ASK1 and p53 | Apoptosis; cancer therapy |
| Thrombomodulin | Cofactor for thrombin that alters substrate specificity via exosite crosstalk | Coagulation research; anticoagulant development |
| Fibrinogen | Substrate for thrombin; binding at exosite I enhances cleavage | Hemostasis; thrombosis models |
| Phospholipids | Endogenous phospholipid allosterically activates Senecavirus A 3Cpro | Viral replication; lipid-protein interactions |
| USP7 inhibitors | Small molecules that inhibit USP7, enhancing CD8+ T cell activity | Cancer immunotherapy; drug discovery |
How Is positive regulation of peptidase activity Regulated?
Positive regulation of peptidase activity is itself tightly regulated at multiple levels. Upstream signaling pathways, such as the CHK2-USP7 axis, can stabilize p53, which in turn transcriptionally activates peptidases involved in apoptosis. The DUSP13A-ASK1 pathway demonstrates how phosphatases can positively regulate kinase cascades that lead to caspase activation. In the coagulation cascade, thrombin generation is amplified by positive feedback loops involving cofactors like thrombomodulin and fibrinogen. Viral proteases, such as Senecavirus A 3Cpro, are regulated by endogenous phospholipids that act as allosteric activators. Additionally, mechanical forces can regulate the activity of Zika virus NS3 helicase, which may impact its protease function. These examples highlight the diverse regulatory inputs that converge on peptidases to enhance their activity.
positive regulation of peptidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KLK6 | Cancer (e.g., breast, colon), neurodegeneration | Knockout and overexpression cell lines; xenograft models |
| USP7 | Liver cancer, immune evasion | CRISPR knockout in CD8+ T cells; syngeneic tumor models |
| CHK2 | Cancer predisposition, oxidative stress response | Point mutation knock-in (e.g., kinase-dead) in cell lines |
| Senecavirus A 3Cpro | Viral infection (Senecavirus A) | Viral protease activity assays; allosteric modulator screens |
| F2 (Thrombin) | Thrombosis, bleeding disorders | Exosite point mutants; coagulation assays |
Cancer
Dysregulated peptidase activity is a hallmark of cancer, contributing to tumor invasion, metastasis, and angiogenesis. Kallikrein-related peptidase 6 (KLK6) is overexpressed in several cancers and its autolytic activation promotes extracellular matrix degradation. The CHK2-USP7-p53 axis is frequently altered in cancers; USP7 inhibitors enhance CD8+ T cell activity by suppressing PRDM1-mediated FGL1 upregulation, providing a therapeutic strategy for liver cancer. Thus, positive regulators of peptidase activity are promising targets for anticancer therapy.
Neurodegenerative Disorders
Altered peptidase activity is implicated in Alzheimer's disease and other neurodegenerative conditions. Aerobic exercise training in late middle-aged adults at risk for Alzheimer's disease altered systemic biomarkers, potentially including peptidases, suggesting a link between lifestyle, peptidase regulation, and cognitive health. Additionally, oxidative stress activates the CHK2-USP7-p53 pathway, which can lead to neuronal apoptosis through peptidase activation. Modulating positive regulation of peptidase activity may offer neuroprotective benefits.
Viral Infections
Many viruses encode peptidases essential for polyprotein processing, and their activity is positively regulated by host or viral factors. Senecavirus A 3Cpro is allosterically activated by an endogenous phospholipid, which is required for efficient viral replication. Zika virus NS3 helicase activity is mechanically regulated, and this may affect its protease domain. Targeting these positive regulatory mechanisms could lead to broad-spectrum antivirals.
Thrombosis and Hemostasis
Thrombin is a central peptidase in coagulation, and its activity is positively regulated by exosite crosstalk with cofactors such as thrombomodulin and fibrinogen. Imbalances in this regulation can cause thrombosis or bleeding disorders. Understanding the molecular details of thrombin exosite crosstalk may inform the design of safer anticoagulants.
From positive regulation of peptidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate peptidase Y? | CRISPR knockout of gene X followed by peptidase activity assay |
| Does a specific point mutation in a peptidase alter its regulation? | CRISPR point mutation knock-in (e.g., active site mutant) |
| Does overexpression of a regulator enhance peptidase activity? | CRISPRa or lentiviral overexpression |
| What is the interactome of a peptidase regulator? | Tagged knock-in (e.g., GFP, BioID) followed by proteomics |
| Can a drug modulate positive regulation of peptidase activity? | CRISPR library screening with drug selection |
| Is the regulation conserved across species? | Orthologous knockout models in zebrafish or mouse |
How to Study the positive regulation of peptidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Protease activity assay | Enzymatic hydrolysis of peptide substrates | Quantify positive regulation by cofactors or mutations |
| Phosphoproteomics | Global phosphorylation changes | Identify signaling pathways that regulate peptidases |
| Ubiquitinomics | Ubiquitination/deubiquitination events | Study USP7-mediated stabilization of p53 |
| CRISPR knockout screen | Loss-of-function effects on peptidase activity | Discover novel positive regulators |
| CRISPR activation screen | Gain-of-function effects on peptidase activity | Identify genes whose overexpression enhances activity |
| Cryo-EM | 3D structure of peptidase complexes | Visualize allosteric activation by phospholipids |
| Surface plasmon resonance | Binding kinetics between peptidase and regulators | Measure exosite interactions in thrombin |
| SDS-PAGE and immunoblotting | Autolytic processing and protein stability | Assess KLK6 autolysis and p53 stabilization |
Protease Activity Assays
Direct measurement of peptidase activity using fluorogenic or colorimetric substrates is the gold standard. For example, thrombin activity can be monitored with chromogenic substrates, and the effects of exosite mutations can be quantified. Similarly, KLK6 autolytic activation can be assessed by SDS-PAGE and activity assays. These methods are essential for confirming positive regulation.
Phosphoproteomics and Ubiquitinomics
Post-translational modifications often regulate peptidase activity. Mass spectrometry-based phosphoproteomics can identify phosphorylation events on peptidases or their regulators, such as CHK2-mediated phosphorylation of p53. Ubiquitinomics can reveal deubiquitination events mediated by USP7. These techniques provide a global view of regulatory networks.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that positively regulate peptidase activity. For instance, a screen for regulators of USP7-dependent CD8+ T cell activity could uncover novel peptidase regulators. Libraries targeting kinases, phosphatases, or proteases are particularly useful. Hits are validated with individual assays.
Structural Biology and Biophysics
Understanding allosteric regulation requires structural insights. X-ray crystallography or cryo-EM can reveal conformational changes in Senecavirus A 3Cpro upon phospholipid binding. Isothermal titration calorimetry and surface plasmon resonance can measure binding affinities and kinetics. These methods elucidate the molecular basis of positive regulation.
How CRISPR Can Be Used to Study GO:0010952 positive regulation of peptidase activity
Knockout
CRISPR knockout is used to delete genes encoding peptidases or their positive regulators to assess loss of function. For example, knocking out USP7 in liver cancer cells enhances CD8+ T cell activity by suppressing PRDM1-mediated FGL1 upregulation. Similarly, knocking out CHK2 would destabilize p53 and reduce peptidase activation under oxidative stress. Knockout models are essential for validating causal roles.
Point Mutation
CRISPR point mutation knock-in introduces specific amino acid changes to dissect regulatory sites. For instance, mutating thrombin exosite residues can reveal their role in exosite crosstalk and substrate specificity. Point mutations in the active site of KLK6 can prevent autolytic activation. These models provide mechanistic insights without completely abolishing protein expression.
Knock-in
Knock-in of tags or reporters allows visualization and interaction studies. A GFP knock-in of a peptidase can track its localization and activation in live cells. BioID knock-in can identify proximity interactors that positively regulate peptidase activity. These models are valuable for understanding spatiotemporal regulation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression is used to increase levels of a candidate regulator and test whether it enhances peptidase activity. For example, overexpressing DUSP13A positively regulates ASK1 and downstream caspases. Overexpression of Senecavirus A 3Cpro in cells can be used to study its allosteric activation by phospholipids. This approach is complementary to knockout.
How EDITGENE Supports positive regulation of peptidase activity Research
Researchers studying positive regulation of peptidase activity-related genes often need to determine whether a candidate gene is causally involved in enhancing peptidase function. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery, from generating knockout cell lines to performing genome-wide screens.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of peptidase activity research.
Frequently Asked Questions About positive regulation of peptidase activity
What is positive regulation of peptidase activity?
Positive regulation of peptidase activity (GO:0010952) is any process that increases the frequency, rate or extent of peptidase activity, which is the hydrolysis of peptide bonds within proteins.
What genes are involved in positive regulation of peptidase activity?
Key genes include F2 (thrombin), KLK6, CHK2, USP7, DUSP13A, ASK1, and viral proteases such as Senecavirus A 3Cpro.
How is peptidase activity positively regulated?
Mechanisms include allosteric activation by ligands, autolytic processing, post-translational modifications like phosphorylation and deubiquitination, cofactor binding, and transcriptional upregulation.
What diseases are associated with dysregulated peptidase activity?
Cancer, neurodegenerative disorders, viral infections, and thrombosis are linked to altered positive regulation of peptidase activity.
What is the role of thrombin exosite crosstalk in peptidase regulation?
Exosite crosstalk in thrombin allows cofactors and substrates to modulate active site specificity and enhance activity, which is critical for hemostasis.
How does USP7 regulate peptidase activity?
USP7 deubiquitinates and stabilizes p53, which can transcriptionally activate peptidases involved in apoptosis; this axis is important in cancer and oxidative stress.
Can CRISPR be used to study positive regulation of peptidase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of genes that regulate peptidase activity.
What methods measure peptidase activity?
Protease activity assays using fluorogenic or colorimetric substrates, SDS-PAGE for autolysis, and phosphoproteomics for regulatory modifications are commonly used.
What is the link between exercise and peptidase activity?
Aerobic exercise training alters systemic biomarkers, potentially including peptidases, in adults at risk for Alzheimer's disease, suggesting a role in metabolic and cognitive health.
How do viral proteases undergo positive regulation?
Viral proteases like Senecavirus A 3Cpro are allosterically activated by endogenous phospholipids, enhancing viral polyprotein processing.
Conclusion
GO:0010952, positive regulation of peptidase activity, is a fundamental biological process that controls proteolysis in health and disease. From allosteric activation of viral proteases to autolytic processing of kallikrein-related peptidases and post-translational stabilization of p53, diverse mechanisms converge to enhance peptidase function. Dysregulation of these processes contributes to cancer, neurodegeneration, viral infections, and thrombosis, making them attractive therapeutic targets. Advances in CRISPR-based models and screening technologies are accelerating the discovery of novel regulators and their causal roles. EDITGENE's comprehensive services support researchers in dissecting these pathways with precision and scale.
References
- 1. Gaitán JM et al.. 2021. Effects of Aerobic Exercise Training on Systemic Biomarkers and Cognition in Late Middle-Aged Adults at Risk for Alzheimer's Disease.. Front Endocrinol (Lausanne) 12:660181 PMID: 34093436
- 2. Zhao HF et al.. 2023. Allosteric regulation of Senecavirus A 3Cpro proteolytic activity by an endogenous phospholipid.. PLoS Pathog 19(5):e1011411 PMID: 37253057
- 3. Cao X et al.. 2022. Mechanical regulation of the helicase activity of Zika virus NS3.. Biophys J 121(24):4900-4908 PMID: 35923103
- 4. Fredenburgh JC et al.. 2025. Exosite crosstalk in thrombin.. J Thromb Haemost 23(4):1160-1168 PMID: 39842513
- 5. Liu J et al.. 2024. The phosphorylation-deubiquitination positive feedback loop of the CHK2-USP7 axis stabilizes p53 under oxidative stress.. Cell Rep 43(6):114366 PMID: 38879877
- 6. Blaber SI et al.. 2007. The autolytic regulation of human kallikrein-related peptidase 6.. Biochemistry 46(17):5209-17 PMID: 17417874
- 7. Park JE et al.. 2010. Positive regulation of apoptosis signal-regulating kinase 1 by dual-specificity phosphatase 13A.. Cell Mol Life Sci 67(15):2619-29 PMID: 20358250
- 8. Sun LL et al.. 2024. Inhibition of USP7 enhances CD8(+) T cell activity in liver cancer by suppressing PRDM1-mediated FGL1 upregulation.. Acta Pharmacol Sin 45(8):1686-1700 PMID: 38589688
